Featured
Last news
Ambience Healthcare Joins Epic Toolbox, Unlocking Advanced AI Functionality Within Haiku for Epic Customers
SAN FRANCISCO, CA / ACCESS Newswire / August 15, 2025 / Ambience Healthcare, a leading AI platform for documentation, coding, and clinical documentation integrity (CDI), today announced it has joined Epic's Toolbox program for Ambient Voice Recognition.
Wi2Wi Corporation Announces Second Quarter 2025 Financial Results
TORONTO, ON / ACCESS Newswire / August 15, 2025 / Wi2Wi Corporation (TSXV:YTY)(OTC PINK:ISEYF) a leader in precision timing devices, frequency control products, and wireless technologies, today announced its financial results for the second quarter ended June 30, 2025.
CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Strong cash position of $12.1 million expected to fund operations into the second half of 2026Driving lead program, TPI 287, towards Phase 2 study for treatment of glioblastoma multiforme (GBM)
CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates
CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business UpdatesEntered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all shares of CureVac, uniting two highly complementary German companies to bring transformative mRNA-based treatments to patients globallyEntered into agreements to resolve and dismiss all pending patent litigation in the U.S. with Pfizer/BioNTech related to mRNA-based COVID-19 vaccines and to set a framework for resolving related ongoing patent disputes outside the U.S. upon closing of BioNTech's acquisition of CureVacReceived Clinical Trial Application (CTA) clearance from the European Medicines Agency (EMA) for CVHNLC, a proprietary off-the-shelf cancer immunotherapy candidate targeting squamous non-small cell lung cancer (sqNSCLC)CVGBM glioblastomadata from Part B of Phase 1 remain on track for H2 2025Strong cash and cash equivalents position of €392.7 million as of June 30, 2025; expected cash runway into 2028
Borussia Dortmund Publishes Preliminary Figures for the 2024/2025 Financial Year
DORTMUND, DE / ACCESS Newswire / August 15, 2025 / Financial year 2024/2025 saw Borussia Dortmund generate its highest-ever consolidated revenue. This was due to increased income from TV marketing, advertising and match operations, which enabled Borussia Dortmund to surpass the previous record it set in the prior year. Consolidated revenue rose by EUR 16.9 million or 3.3% to EUR 526.0 million. Consolidated total operating proceeds (consolidated revenue plus gross transfer proceeds generated) declined to EUR 589.6 million (previous year: EUR 639.0 million) due to lower gross transfer proceeds. The consolidated net income for financial year 2024/2025 amounted to EUR 6.5 million, after EUR 44.3 million in the previous year.
Encision Reports First Quarter Fiscal Year 2026 Results
BOULDER, CO / ACCESS Newswire / August 15, 2025 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 first quarter that ended June 30, 2025.
The Untold Truth About President Trump's Marijuana Rescheduling
The untold truth? Rescheduling may not save the cannabis industry-it could divide it.Past IRS 280E tax liabilities won't vanish-some companies owe hundreds of millions.Interstate cannabis operators still remain barred from DEA licensing, regardless of tax changes.Marijuana is still DEA regulated under the Controlled Substance Act andQuota is still the 800 pound gorilla in the room.
Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Third Patient Treated with HG-CT-1 CAR-T Therapy and Completion of First Adult Dose Cohort
New clashes in Serbia as political crisis escalates
Clashes between rival groups of protesters in Serbia flared again late Thursday, police said, as months of anti-government demonstrations boiled over into street violence this week.
Germany sacks rail chief with train network in crisis
The German government sacked the embattled head of Deutsche Bahn on Thursday as it seeks to overhaul the ailing public rail network after years of criticism about deteriorating services.
Greek firefighters beat back wildfires
Greek firefighters gained ground Thursday against a wildfire outside the third-largest city of Patras, while planes bombed water on blazes on three other fronts.
Serbia's political crisis escalates into clashes
Clashes between rival groups of protesters in Serbia left dozens injured overnight, police said Thursday, as months of anti-government demonstrations boiled over into street violence for a second night.
Greek firefighters make progress against wildfires
Firefighters in Greece gained ground Thursday against a wildfire outside the third-largest city of Patras, while water bombers battled blazes on three other fronts.
Inside Trump's 'Alligator Alcatraz': detainees allege abuse in a legal black hole
At US President Donald Trump's new migrant detention center in the Florida Everglades, time has no discernible meaning.
Labor Smart, Inc. - Letter from the CEO Q2 2025 Shareholder Update
Labor Smart, Inc. (OTCID:LTNC) - Letter from the CEO about Q2 2025 Financial Reporting
SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology
Marketing approval allows imminent commercialization of the Colovac device in key EU markets
Applied DNA Reports Third Quarter Fiscal 2025 Financial Results
STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial results for its third quarter of fiscal 2025 ended June 30, 2025. The Company's Form 10-Q for its fiscal third quarter can be viewed on the SEC Filings page of its Investor Relations website. The Company will not host a conference call to discuss these results. Applied DNA investor relations remains available for questions at [email protected] .
Wirsh Unveiled Geimori T38: The True Pro-Grade Wireless Electric Portable Coffee Grinder
Innovating on-the-go grinding with uncompromised quality and effortless precision
Laser Photonics (NASDAQ: LASE) Launches One-Year Integrated Media Partnership with New to The Street
Comprehensive campaign features long-form national TV interviews as sponsored programming, monthly earned media, high-frequency commercials, and iconic outdoor advertising
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
KELOWNA, BC / ACCESS Newswire / August 14, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization ("CRO") has completed the important study milestone known as last patent last visit ("LPLV") in Lexaria's Phase 1b glucagon-like peptide-1 ("GLP-1") study in Australia, GLP-1-H24-4 (the "Study").
Patriot.TV Adds "The David Pollack Show" Expanding it's Weekly Lineup - Riding a Wave of Victories as Viewers Abandon Legacy Media for Streaming and Truth-Based Conservative Reporting
Patriot.TV's Ascent Coincides with a Broader Industry Shift Favoring New Media Over Legacy Networks and Conservative Over Liberal Outlets.
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
- Live video webcast on Tuesday, August 19th at 2:40 PM ET
Maison Solutions Reports Fiscal Year 2025 Financial Results
MONTEREY PARK, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the fiscal year ended April 30, 2025.
Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy
TAMPA, FLORIDA / ACCESS Newswire / August 14, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the termination of its equity purchase agreement ("ELOC") with Hudson Global Ventures, LLC.
Interactive Strength Inc. (Nasdaq:TRNR) Reports Second Quarter 2025 Results; Increases 2025 Pro Forma Revenue Guidance to More Than $80M
Company Reports Quarterly Revenue of $1.2 Million; Net Loss and Loss per Diluted Share of $2.2 Million and $2.13Quarterly Adjusted EBITDA Loss of $1.7 Million Reflects 40% YOY ImprovementTRNR held 29.6 Million FET tokens as of June 30, 2025 and 67.4 Million FET tokens as of August 13, 2025, with a value in excess of $50 million, representing the largest publicly traded AI-focused Digital Asset TreasuryStockholders' Equity Was $16.3 Million at Quarter End2025 Pro Forma Revenue Guidance Increased to more than $80 Million, driven by Sportstech's Stronger-Than-Expected Performance, and Fourth Quarter Profitability Guidance Reiterated
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20
ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_5UneWjXKTOuzgbB4wpeByg
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately 35% versus net Q1 2025 revenue of approximately $2.2 million and increased approximately 10% versus net Q2 2024 revenue of approximately $2.7 millionMytesi prescription volume increased approximately 6.5% in Q2 2025 over Q1 2025 and Mytesi prescription volume in Q2 2025 was equal to the volume in Q2 2024As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome (SBS-IF) patient by up to 12.5%; FDA meeting resulted in planned Jaguar regulatory pathway to complete supplemental NDA strategy for crofelemer for patients with metastatic breast cancer, a population meeting orphan definition in USCompany strategy: Seek business development partnerships for license to develop and commercialize Jaguar's orphan indication products, resulting in non-dilutive funding for JaguarREMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q2 2025 financials and company updates; Click here to register
ANITA & ZAHA Introduces Exclusive "Made in France" Natural Cosmetics
ANITA & ZAHA unveils a premium natural cosmetics range made in France, blending over 93% natural ingredients, luxury design, and eco-conscious values for modern, mindful beauty lovers.
Relief Therapeutics Publishes 2025 Half-Year Report
GENEVAD, SE / ACCESS Newswire / August 14, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced the publication of its 2025 half-year report and provided a corporate update.
Storm makes landfall in China after raking Taiwan as typhoon
Typhoon Podul weakened to a severe tropical storm when it roared ashore in southeastern China early Thursday, state media said, after carving a path across Taiwan, shutting down businesses, grounding flights and knocking out power to thousands of homes.
At least 26 migrants dead in two shipwrecks off Italy
At least 26 migrants died Wednesday when two boats sank off the coast of Italy's Lampedusa island, with around 10 others still missing, the coastguard and UN officials said.
Massive fire burns on mountain near western Canada city
Nearly 20,000 residents of a community in western Canada were on standby Wednesday as a wildfire engulfed a mountain overlooking the city of Port Alberni, the latest area threatened in the country's second-worst fire season on record.